About Premier Biotech
Premier Biotech is a company based in Minneapolis (United States) founded in 2009. The company has 102 employees as of December 31, 2022. Premier Biotech has completed 1 acquisition, including Desert Tox. Premier Biotech operates in a competitive market with competitors including Assurex Health, Genomind, BioBDx, Taliaz Health and CNSDose, among others.
- Headquarter Minneapolis, United States
- Employees 102 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Premier Biotech, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
102
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Premier Biotech
Unlock access to complete
Funding Insights of Premier Biotech
Investors in Premier Biotech
Premier Biotech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Align Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are made in lower-middle market companies.
|
Locked | Locked | Locked |
Investor details for Premier Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Premier Biotech
Premier Biotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Desert Tox.
Investment portfolio details for Premier Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug testing services for workplaces are provided in Arizona.
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for Premier Biotech
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Premier Biotech
Detailed financials for Premier Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Premier Biotech Comparisons
Peer comparison for Premier Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Premier Biotech
Premier Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Assurex Health, Genomind, BioBDx, Taliaz Health and CNSDose, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Personalized medication for neuropsychiatric conditions is guided by pharmacogenomics.
|
|
| Locked | Locked | Locked |
Genetic tests for personalized mental health treatments are developed.
|
|
| Locked | Locked | Locked |
Tools for ADHD symptom assessment via motion tracking are developed.
|
|
| Locked | Locked | Locked |
Pharmacogenomics for psychological disorders
|
|
| Locked | Locked | Locked |
Pharmacogenomics tools for anti-depressant regimens are developed.
|
Detailed competitors of Premier Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Premier Biotech
Complete news archive for Premier Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Premier Biotech
Premier Biotech was founded in 2009 and raised its 1st funding round 13 years after it was founded.
Premier Biotech is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
As of Dec 31, 2022, the latest employee count at Premier Biotech is 102.
Premier Biotech was founded in 2009 in Minneapolis, United States, within the biotechnology sector focused on drug monitoring. Rapid testing options for 18 controlled substances and alcohol are supplied through urine cups, dips, CLIA-waived tests, and oral fluid methods. Lab services are extended to support clinical, criminal justice, health and human services, and workplace programs. Operations center on these diagnostic tools and analytical support.
Premier Biotech's top competitors include Assurex Health, Genomind and CNSDose.
Premier Biotech has made 1 acquisition, including Desert Tox.
Premier Biotech has 1 investor. Key investors include Align Capital Partners.